Glycated hemoglobin is associated with the complexity of coronary artery disease, even in non-diabetic adults

Journal of Atherosclerosis and Thrombosis

Volumn 19, Issue 12, 2012, Pages 1066-1072

  Ikeda, Nobutaka ^a   Iijima, Raisuke ^b   Hara, Hisao ^a   Moroi, Masao ^a   Nakamura, Masato ^b   Sugi, Kaoru ^b  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b TOHO UNIVERSITY OHASHI MEDICAL CENTER   (Japan)

Author keywords

Diabetes mellitus; Glucose; Stable coronary artery disease; SYNTAX score

Indexed keywords

HEMOGLOBIN A1C;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; SYNTAX SCORE;

ADULT; AGE FACTORS; AGED; BLOOD GLUCOSE; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CREATININE; CROSS-SECTIONAL STUDIES; DYSLIPIDEMIAS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; JAPAN; MALE; MIDDLE AGED; ODDS RATIO; REGRESSION ANALYSIS; RENAL DIALYSIS; RISK;

EID: 84868626870     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.13722     Document Type: Article

References (34)

1. American Diabetes Association: Standards of medical care in diabetes--2009. Diabetes Care, 2009; 32 Suppl 1: S13-61
2. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care, 2009; 32 Suppl 1: S62-67
3. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care, 2010; 33 Suppl 1: S62-69
4. The Committee of Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. Mellitus: Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. J. Jpn. Diabetes Soc, 2010; 53: 450-467
5. Phillipou G, Phillips PJ: Intraindividual variation of glycohemoglobin: Implications for interpretation and analytical goals. Clin Chem, 1993; 39: 2305-2308
6. Rohlfing C, Wiedmeyer HM, Little R, Grotz VL, Tennill A, England J, Madsen R, Goldstein D: Biological variation of glycohemoglobin. Clin Chem, 2002; 48: 1116-1118
7. Selvin E, Crainiceanu CM, Brancati FL, Coresh J: Short-term variability in measures of glycemia and implications for the classification of diabetes. Arch Intern Med, 2007; 167: 1545-1551
8. Stolar M: Glycemic control and complications in type 2 diabetes mellitus. Am J Med, 2010; 123: S3-11
9. Irie Y, Sakamoto K, Kubo F, Okusu T, Katura T, Yamamoto Y, Umayahara Y, Katakami N, Kaneto H, Kashiyama T, Ueda Y, Kosugi K: Association of coronary artery stenosis with carotid atherosclerosis in asymptomatic type 2 diabetic patients. J Atheroscler Thromb, 2011; 18: 337-344
10. Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J, Coresh J, Brancati FL: Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med, 2010; 362: 800-811
11. Scherff F, Vassalli G, Sürder D, Mantovani A, Corbacelli C, Pasotti E, Klersy C, Auricchio A, Moccetti T, Pedrazzini GB: The SYNTAX score predicts early mortality risk in the elderly with acute coronary syndrome having primary pci. J Invasive Cardiol, 2011; 23: 505-510
12. Brito J, Teles R, Almeida M, de Araújo Gonçalves P, Raposo L, Sousa P, Mendes M: Predictive value of SYNTAX score in risk stratification of patients undergoing unprotected left main coronary artery angioplasty. J Invasive Cardiol, 2011; 23: 494-499
13. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, Ståhle E, Feldman TE, van den Brand M, Bass EJ, Van Dyck N, Leadley K, Dawkins KD, Mohr FW, Investigators S: Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med, 2009; 360: 961-972
14. Farooq V, Brugaletta S, Serruys PW: The SYNTAX score and SYNTAX-based clinical risk scores. Semin Thorac Cardiovasc Surg, 2011; 23: 99-105
15. Taggart DP: Lessons learned from the syntax trial for multivessel and left main stem coronary artery disease. Curr Opin Cardiol, 2011; 26: 502-507
16. Kashiwagi A, Kasuga M, Araki E, Oka Y, Hanafusa T, Ito H, Tominaga M, Oikawa S, Noda M, Kawamura T, Sanke T, Namba M, Hashiramoto M, Sasahara T, Nishio Y, Kuwa K, Ueki K, Takei I, Umemoto M, Murakami M, Yamakado M, Yatomi Y, Ohashi H, Committee on the Standardization of Diabetes Mellitus-Related Laboratory Testing of Japan Diabetes Society: International clinical harmonization of glycated hemoglobin in japan: From japan diabetes society to national glycohemoglobin standardization program values. J Diabetes Invest, 2012; 3: 39-40
17. Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Hara S, Ura N, Kiyohara Y, Hirakata H, Watanabe T, Moriyama T, Ando Y, Inaguma D, Narita I, Iso H, Wakai K, Yasuda Y, Tsukamoto Y, Ito S, Makino H, Hishida A, Matsuo S: Estimation of glomerular filtration rate by the mdrd study equation modified for japanese patients with chronic kidney disease. Clin Exp Nephrol, 2007; 11: 41-50
18. Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, van den Brand M, Van Dyck N, Russell ME, Mohr FW, Serruys PW: The SYNTAX Score: An angiographic tool grading the complexity of coronary artery disease. EuroIntervention, 2005; 1: 219-227
19. Morice MC, Serruys PW, Kappetein AP, Feldman TE, Ståhle E, Colombo A, Mack MJ, Holmes DR, Torracca L, van Es GA, Leadley K, Dawkins KD, Mohr F: Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial. Circulation, 2010; 121: 2645-2653
20. Blake GJ, Pradhan AD, Manson JE, Williams GR, Buring J, Ridker PM, Glynn RJ: Hemoglobin a1c level and future cardiovascular events among women. Arch Intern Med, 2004; 164: 757-761
21. Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N: Association of hemoglobin A1c with cardiovascular disease and mortality in adults: The European prospective investigation into cancer in Norfolk. Ann Intern Med, 2004; 141: 413-420
22. Gerstein HC, Swedberg K, Carlsson J, McMurray JJ, Michelson EL, Olofsson B, Pfeffer MA, Yusuf S, Investigators CP: The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Arch Intern Med, 2008; 168: 1699-1704
23. Ceriello A, Hanefeld M, Leiter L, Monnier L, Moses A, Owens D, Tajima N, Tuomilehto J: Postprandial glucose regulation and diabetic complications. Arch Intern Med, 2004; 164: 2090-2095
24. Selvin E, Bolen S, Yeh HC, Wiley C, Wilson LM, Marinopoulos SS, Feldman L, Vassy J, Wilson R, Bass EB, Brancati FL: Cardiovascular outcomes in trials of oral diabetes medications: A systematic review. Arch Intern Med, 2008; 168: 2070-2080
25. Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F, Group AC: Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med, 2008; 358: 2560-2572
26. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, Vitek ME, Henderson WG, Huang GD, Investigators V: Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med, 2009; 360: 129-139
27. Gerstein HC, Miller ME, Byington RP, Goff DC, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH, Probstfield JL, Simons-Morton DG, Friedewald WT, Group AtCCRiDS: Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med, 2008; 358: 2545-2559
28. The Diabetes Control and Complications Trial (DCCT): Design and methodologic considerations for the feasibility phase. The DCCT Research Group. Diabetes, 1986; 35: 530-545
29. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet, 1998; 352: 837-853
30. Valgimigli M, Serruys PW, Tsuchida K, Vaina S, Morel MA, van den Brand MJ, Colombo A, Morice MC, Dawkins K, de Bruyne B, Kornowski R, de Servi S, Guagliumi G, Jukema JW, Mohr FW, Kappetein AP, Wittebols K, Stoll HP, Boersma E, Parrinello G, II A: Cyphering the complexity of coronary artery disease using the syntax score to predict clinical outcome in patients with threevessel lumen obstruction undergoing percutaneous coronary intervention. Am J Cardiol, 2007; 99: 1072-1081
31. Palmerini T, Genereux P, Caixeta A, Cristea E, Lansky A, Mehran R, Dangas G, Lazar D, Sanchez R, Fahy M, Xu K, Stone GW: Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) trial. J Am Coll Cardiol, 2011; 57: 2389-2397
32. Ikeda N, Kogame N, Iijima R, Nakamura M, Sugi K: Carotid artery intima-media thickness and plaque score can predict the SYNTAX score. Eur Heart J, 2012; 33: 113-119
33. Japanese Coronary Artery Disease (JCAD) Study Investigators: Current status of the background of patients with coronary artery disease in Japan. Circ J, 2006; 70: 1256-1262
34. Huxley RR, Woodward M: Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet, 2011; 378: 1297-1305